×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PVLA – palvella therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PVLA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/25
08:48 pm
pvla
New Palvella Director Brings Rare Disease Insight To Low Valued Stock [Yahoo! Finance]
Medium
Report
New Palvella Director Brings Rare Disease Insight To Low Valued Stock [Yahoo! Finance]
4/20
09:27 am
pvla
Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026 [Yahoo! Finance]
Low
Report
Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026 [Yahoo! Finance]
4/20
07:30 am
pvla
Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026
Low
Report
Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026
4/13
07:30 am
pvla
Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors
Low
Report
Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors
4/7
07:30 am
pvla
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Low
Report
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
4/1
11:39 pm
pvla
Palvella's Phase III Success And Fast Track Status Test Current Valuation [Yahoo! Finance]
Low
Report
Palvella's Phase III Success And Fast Track Status Test Current Valuation [Yahoo! Finance]
3/31
05:23 pm
pvla
Palvella Therapeutics (PVLA) had its price target raised by Chardan Capital from $210.00 to $240.00. They now have a "buy" rating on the stock.
Medium
Report
Palvella Therapeutics (PVLA) had its price target raised by Chardan Capital from $210.00 to $240.00. They now have a "buy" rating on the stock.
3/31
03:22 pm
pvla
Palvella Therapeutics Inc (PVLA) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
Low
Report
Palvella Therapeutics Inc (PVLA) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/31/2026
07:30 am
PVLA
palvella therapeutics, inc.
MISS
Report
12.6%
palvella therapeutics, inc.
11/11/2025
07:30 am
PVLA
palvella therapeutics, inc.
MISS
Report
-4.6%
palvella therapeutics, inc.
8/14/2025
07:30 am
PVLA
palvella therapeutics, inc.
MISS
Report
3.9%
palvella therapeutics, inc.
5/15/2025
07:30 am
PVLA
palvella therapeutics, inc.
BEAT
Report
4.6%
palvella therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/17
04:05 pm
pvla
Form 4 PALVELLA THERAPEUTICS, For: Apr 15 Filed by: Goin Kathleen
Low
Report
Form 4 PALVELLA THERAPEUTICS, For: Apr 15 Filed by: Goin Kathleen
4/15
04:06 pm
pvla
Form 4 PALVELLA THERAPEUTICS, For: Apr 13 Filed by: Doux John
Medium
Report
Form 4 PALVELLA THERAPEUTICS, For: Apr 13 Filed by: Doux John
4/15
04:05 pm
pvla
Form 3 PALVELLA THERAPEUTICS, For: Apr 13 Filed by: Doux John
Medium
Report
Form 3 PALVELLA THERAPEUTICS, For: Apr 13 Filed by: Doux John
4/15
04:00 pm
pvla
Form 144 PALVELLA THERAPEUTICS, Filed by: Goin Kathleen
Medium
Report
Form 144 PALVELLA THERAPEUTICS, Filed by: Goin Kathleen
4/13
07:30 am
pvla
Form 8-K PALVELLA THERAPEUTICS, For: Apr 13
Low
Report
Form 8-K PALVELLA THERAPEUTICS, For: Apr 13
4/7
07:31 am
pvla
Form 8-K PALVELLA THERAPEUTICS, For: Apr 07
Medium
Report
Form 8-K PALVELLA THERAPEUTICS, For: Apr 07
4/1
04:06 pm
pvla
Form 4 PALVELLA THERAPEUTICS, For: Mar 30 Filed by: JENKINS GEORGE M
Low
Report
Form 4 PALVELLA THERAPEUTICS, For: Mar 30 Filed by: JENKINS GEORGE M
3/31
08:31 am
pvla
Form 10-K PALVELLA THERAPEUTICS, For: Dec 31
High
Report
Form 10-K PALVELLA THERAPEUTICS, For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: